Jenene Thomas
INDEPENDENT Director, chairman of compensation & Member of audit and nominating Committee
Ms. Thomas has an extensive network and expertise in investor relations and corporate communications, with a proven track record with more than 20 years of creating and executing comprehensive, global communications programs and increasing corporate visibility among multiple key audiences including investors, potential partners and media. She is currently Chief Executive Officer of JTC Team, LLC, a fully integrated corporate communications firm assisting companies with investor relations and media communication, which she founded in 2012. Prior to 2012, Ms. Thomas served as Vice President of Investor Relations and Business Administration at Unigene Laboratories, where she served in that position from 2019 to 2012. From 2008 to 2010, Ms. Thomas served as Director, Investor Relations and Corporate Communications at Amicus Therapeutics. The Board nominated Ms. Thomas to serve as a director because of her leadership in the finance industry, investor communications, and assisting companies with capital raising. She has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.